Multiple Receptors and Binding Sites for Tachykinins

  • L. L. Iversen
  • A. C. Foster
  • K. J. Watling
  • A. T. McKnight
  • B. J. Williams
  • C. M. Lee
Conference paper


The evidence for the existence of multiple classes of receptor for the naturally occurring tachykinins has been reviewed previously [1–4]. Our original proposal for a sub-division of SP-P and SP-E receptors [1] was based on pharmacological data. showing differences in the relative potencies of tachykinins in different peripheral tissue bioassays. These differences have since been confirmed in other laboratories [5,6]. More recently. several different radiolabelled tachykinin derivatives have been used to characterise tachykinin receptors in peripheral tissues and in CNS. Using binding studies [7–10]. Such studies have suggested that there may be three rather than two types of tachykinin receptor binding sites in mammalian tissues. and some of these findings will be reviewed here and by the contributors to this symposium session.


Multiple Receptor Tachykinin Receptor Multiple Binding Site Inositol Phospho Symposium Session 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lee C M. Iversen L L. Hanley M R & Sandberg B E B. (1982) The possible existence of multiple receptors for substance P N S Archiv Pharmacol 318: 281–287.CrossRefGoogle Scholar
  2. 2.
    Erspamer G F. Erspamer V. Pigginelli D. (1980) Parallel bioassay of physalaemin and kassinin. a tachykinin dodecapeptide from the skin of the African frog Kasina sereqalensis. N S Archiv Pharmacol 311 : 61–65.CrossRefGoogle Scholar
  3. 3.
    Iversen L L. (1984) Pharmacological approaches to neuropeptide function: substance P. IUPHAR 9th International Congress of Pharmacology. W Paton. J Mitchell & P Turner (eds) Vol 1. pp 31–41. Macmillan. London.Google Scholar
  4. 4.
    Iversen L L. (1985) Multiple receptors for tachykinins. In “Tachykinin Antagonists”. R Hakanson & F Sundler (eds) pp 291–304. Elsevier. Amsterdam.Google Scholar
  5. 5.
    Mizrahi J. Dion S. D’Orleans-Juste P. Escher E. Drapeau G & Regoli D. (1985) Tachykinin receptors in smooth muscles: a study with agonists (substance p. neurokinin A) and antagonists. Eur J Pharmacol 118: 25–36.PubMedCrossRefGoogle Scholar
  6. 6.
    Bailey S J. Featherstone R L. Jordan C C & Morton I K M. (1986) An examination of the pharmacology of two substance P antagonists and evidence for tachykinin receptor subtypes. Br J Pharmacol 87 : 79–85.PubMedGoogle Scholar
  7. 7.
    Cascieri M A. Chicchi G G & Liang T. (1985) Demonstration of two distinct tachykinin receptors in rat brain cortex. J Bibl Chem 260: 1501–1507.Google Scholar
  8. 8.
    Buck S H. Burcher E. Schults C W. Lovenberg W & O’Donohue T L. (1985) Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science 226:987–989.CrossRefGoogle Scholar
  9. 9.
    Bahouth S W. Lazaro D M. Brundich D E & Musacchio J M. (1985) Specific binding of [3H_Tyr8 ] physalaemin to rat submaxillary gland substance P receptor. Mol Pharmacol 27: 38–45.PubMedGoogle Scholar
  10. 10.
    Beaujouan J C. Torrens Y. Viger A & Glowinski J.,(1984) A new type of tachykinin binding in the rat brain characterized by specific binding of a labelled eledoisin derivative. Mol Pharmacol 26: 248–254.PubMedGoogle Scholar
  11. 11.
    Mohini P. Bahouth S W. Brundish D E. & Musacchio J M. (1985) Specific labelling of rat brain substance P receptor with [3H] physalaemin. J Neuroscience 5: 2078–2085.Google Scholar
  12. 12.
    Torrens Y. Lavielle S. Chassaing G. Marquet A. Glowrinski J & Beaujonan J C. (1984) Neuromedin K. a tool to further distinguish two central tachykinin binding sites. Eur J Pharmacol. 102: 381–382.PubMedCrossRefGoogle Scholar
  13. 13.
    Laufer R. Wormser U. Friedman Z Y. Gilon C. Chorev M & Selinger Z. (1985) Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonised by enkephalin. Proc Nat Acad Sci. US. 82: 7444–7448.CrossRefGoogle Scholar
  14. 14.
    Lee C M. Campbell N J. Williams B J & Iversen L L. (1986) Multiple tachykinin binding sites in peripheral tissues and in brain. Eur J Pharmacol (in press).Google Scholar
  15. 15.
    Foster A C & Tridgett R. (1986) Tachykinin receptors in rat cerebral cortex: [ 1251] BoltonHunter-labelled eledoisin and neurokinin A label a common site. Br J Pharmacol (in press).Google Scholar
  16. 16.
    Burcher E. Buck S H. Lovenberg W & O’Donohue T L. (1986) Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacol expo Ther 236: 819–831.Google Scholar
  17. 17.
    Watson S P. Sandberg B E B. Hanley M R & Iversen L L. (1983) Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol 87 77–84.PubMedCrossRefGoogle Scholar
  18. 18.
    Piercey M. F. Dorby-Schreur P J K. Masiques N & Schroeder L A. (1985) Stereospecificity of SP1 and SP2 substance P receptors. Life Sciences 36: 777–780.PubMedCrossRefGoogle Scholar
  19. 19.
    Hanley M R. Lee C M. Jones L M & Mitchell R H. (1980) Similar effects of substance P and related peptides on salivation and phosphatidylinositide turnover in rat salivary glands. Mol Pharmacol 18: 78–83.PubMedGoogle Scholar
  20. 20.
    Watson S. P. (1984) The action of substance P on contraction, inositol phospholipids and adenylate cyclase in rat small intestine. Biochem Pharmacol 33 3733–3737.PubMedCrossRefGoogle Scholar
  21. 21.
    Bristow D R, Suman-Chauhan N & Watling K J, (1986) Effects of tachykinins on inositol phospholipids hydrolysis in slices of hamster urinary bladder. Br J Pharmacol (submitted)Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1987

Authors and Affiliations

  • L. L. Iversen
    • 1
  • A. C. Foster
    • 1
  • K. J. Watling
    • 1
  • A. T. McKnight
    • 1
  • B. J. Williams
    • 1
  • C. M. Lee
    • 1
  1. 1.Merck Sharp & Dohme Research LaboratoriesNeuroscience Research CentreHarlowEngland

Personalised recommendations